Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Quarterly results
Acq. announced
Director departure
Appointed director
Adams Respiratory Therapeutics, Inc. (ARXT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/04/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2008 8-K Quarterly results
01/29/2008 8-K Completion of Acquisition or Disposition of Assets
12/10/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Adams Respiratory Therapeutics, Inc., Reckitt Benckiser Group plc and Twickenham, Inc"
11/09/2007 10-Q Quarterly Report for the period ended September 30, 2007
11/08/2007 8-K Investor presentation, Quarterly results
Docs: "Slide presentation to be presented November 8, 2007"
10/29/2007 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/30/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Form of Stock Option Certificate",
"Form of Service-Based Restricted Stock Unit Certificate",
"Form of Performance-Based Restricted Stock Unit Certificate"
08/29/2007 10-K Annual Report for the period ended June 30, 2007
08/21/2007 8-K Investor presentation, Quarterly results
Docs: "Exhibit 99.1",
"Slide presentation to be presented August 21, 2007"
06/13/2007 8-K Appointed a new director
Docs: "Form of Change in Control Agreement",
"Adams Respiratory Therapeutics, Inc. Severance Pay Plan"
06/08/2007 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
05/30/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "FDA TAKES ACTION AGAINST UNAPPROVED TIMED-RELEASE GUAIFENESIN PRODUCTS, INCLUDING PRESCRIPTION VERSIONS OF MUCINEX ® DM AND MUCINEX ® D"
05/15/2007 10-Q Quarterly Report for the period ended March 31, 2007
05/10/2007 8-K Investor presentation, Quarterly results
Docs: "4 Mill Ridge Lane Mill Ridge Farm Chester, NJ 07930 Main: 908-879-1400 Fax: 908-879-9191 www.adamsrt.com",
"Slide presentation to accompany the May 10, 2007 conference call"
04/25/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Other Events, Financi...
Docs: "PRESS RELEASE DATED 4-25-07"
04/04/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slides to be presented on April 4, 2007 by Rita O'Connor",
"Slides to be presented on April 4, 2007 by Bob Casale",
"Slides to be presented on April 4, 2007 by Ken Miller and Tim Miller",
"Slides to be presented on April 4, 2007 by Helmut Albrecht",
"Slides to be presented on April 4, 2007 by Michael Valentino",
"PRESS RELEASE DATED 4-4-07"
03/22/2007 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "PRESS RELEASE DATED 3-21-07"
03/16/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "Net sales expected to be in the range of $80 million to $85 million in fiscal 2007 third quarter; and $320 million to $335 million for the 2007 fiscal year"
03/07/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Separation and Independent Consulting Agreement, by and between the Company and David P. Becker",
"Income Security Agreement, by and between the Company and Rita M. O'Connor"
02/14/2007 10-Q Quarterly Report for the period ended December 31, 2006
02/08/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slides to be presented at the Merrill Lynch 18th Annual Global Pharmaceutical, Biotechnology and Medical Device Conference on February 8, 2007"
02/07/2007 8-K Investor presentation, Appointed CFO, Quarterly results
Docs: "Second Quarter Financial Highlights:",
"Slide presentation to be presented February 7, 2007",
"ADAMS RESPIRATORY THERAPEUTICS ANNOUNCES RESIGNATION OF CHIEF FINANCIAL AND ADMINISTRATIVE OFFICER AND TREASURER",
"ADAMS RESPIRATORY THERAPEUTICS ANNOUNCES PROMOTION OF RITA M. O'CONNOR TO CHIEF FINANCIAL OFFICER AND TREASURER"
01/10/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slides to be presented at the 25th Annual JP Morgan Healthcare Conference on January 10, 2007 and other meetings on January 11-12, 2007"
12/15/2006 8-K Investor presentation
Docs: "Slides to be presented at the Annual Meeting of Stockholders on December 15, 2006"
12/14/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slides to be presented to investors and potential investors beginning December 14, 2006"
12/11/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "Adams to Webcast Management Presentation at the RBC Capital Markets 2006 Healthcare Conference",
"Adams Respiratory Therapeutics Issues Reexamination Update"
11/14/2006 10-Q Quarterly Report for the period ended September 30, 2006
11/14/2006 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Other Events, Financi...
Docs: "DR. ALAN W. DUNTON ELECTED TO BOARD OF DIRECTORS OF ADAMS RESPIRATORY THERAPEUTICS"
11/08/2006 8-K Investor presentation, Quarterly results
Docs: "PRESS RELEASE DATED 11-8-06",
"Slide presentation to be presented November 8, 2006"
10/31/2006 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Other Events, Financi...
Docs: "ADAMS RESPIRATORY THERAPEUTICS ANNOUNCES ORGANIZATIONAL CHANGES"
10/27/2006 DEF 14A Form DEF 14A - Other definitive proxy statements
10/19/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Slides to be presented on October 19, 2006"
09/28/2006 10-K Annual Report for the period ended June 30, 2006
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy